Preukschas, Michael <br/><br/>
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.  [electronic resource] 

 -  PloS one  2012 
 - e43468 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0043468  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis--drug effects<br/>Carmustine--pharmacology<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cellular Senescence--drug effects<br/>Dacarbazine--analogs & derivatives<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Knockdown Techniques<br/>Glioblastoma--drug therapy<br/>Guanine--analogs & derivatives<br/>Humans<br/>Lysine--analogs & derivatives<br/>Male<br/>Mixed Function Oxygenases--genetics<br/>Molecular Targeted Therapy<br/>Neoplasm Grading<br/>Oxidoreductases Acting on CH-NH Group Donors--antagonists & inhibitors<br/>Peptide Initiation Factors--deficiency<br/>RNA-Binding Proteins--genetics<br/>Temozolomide<br/>Eukaryotic Translation Initiation Factor 5A